logo
episode-header-image
Oct 2024
20m 36s

#320 – AMA 64: New insights on GLP-1 ago...

Peter Attia, MD
About this episode

View the Show Notes Page for This Episode

Become a Member to Receive Exclusive Content

Sign Up to Receive Peter’s Weekly Newsletter

In this “Ask Me Anything” (AMA) episode, Peter dives back into the increasingly popular topic of GLP-1 agonists, such as Ozempic and Mounjaro, which have garnered widespread attention for their ability to promote weight loss. Peter covers the latest findings in this rapidly evolving landscape, including new insights into their long-term efficacy, side effects, and what happens when the drug is discontinued. Peter also explores their impact on body composition and how resistance training interacts with these treatments. Additionally, he compares different GLP-1 receptor agonists and discusses promising new drugs in the pipeline. Finally, Peter addresses questions about the role of compounding pharmacies in the GLP-1 agonist market, compares oral vs. injectable options, and provides key considerations for anyone deciding whether to use a GLP-1 agonist for weight loss.

If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #64 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

We discuss:

  • The rapidly evolving landscape of GLP-1 agonists [2:15];
  • The mechanism of GLP-1 agonists, their origin as diabetes treatments, and how they evolved into weight-loss drugs [6:45];
  • Overview of new data and open questions related to the benefits and risks of GLP-1 agonists [10:30];
  • New insights into the long-term safety of GLP-1 agonists, side effects, and more [16:45];
  • The long-term efficacy of GLP-1 agonists, financial barriers, and more [19:45];
  • The mechanisms behind GLP-1 agonists' ability to promote weight loss [22:00];
  • New data on body weight changes after discontinuing the drug [26:00];
  • Effects of GLP-1 agonists on lean mass and body composition, and the role of protein and resistance training in preserving muscle [31:30];
  • Semaglutide vs. tirzepatide: comparing benefits and side effects [36:30];
  • How compounding pharmacies affect availability of GLP-1 drugs and the types of formulations that are available [39:15];
  • How do oral formulations of GLP-1 drugs compare to injectable formulations? [44:15];
  • How do sublingual (under tongue) formulations of GLP-1 drugs compare to injectable formulations? [46:15];
  • Guidance for using compounding pharmacies to purchase GLP-1 agonists [47:15];
  • Data on retatrutide—a promising new triple receptor agonist in the pipeline [50:15];
  • Can GLP-1 agonists be beneficial for sleep apnea and immune function? [57:00];
  • Potential neuroprotective benefits of GLP-1 agonists: impact on dementia risk [1:00:45];
  • Exploring why GLP-1 agonists may reduce the risk of cancer, kidney disease, and cardiovascular disease [1:04:00];
  • How GLP-1 agonists might boost fertility in women [1:10:15];
  • Early indications that GLP-1 agonists may help treat substance abuse disorders [1:12:00];
  • Potential health risks of GLP-1 agonists: addressing thyroid cancer concerns and the unknowns due to lack of data [1:14:00];
  • Examining the potential link between GLP-1 agonists and increased depression or suicidal ideation [1:16:00];
  • Major remaining questions: the effects of cyclic use, rebound appetite, impact on adolescents' development, and more [1:19:30];
  • Key considerations when deciding whether to use a GLP-1 agonist for weight loss [1:23:45]; and
  • More.

Connect With Peter on TwitterInstagramFacebook and YouTube

Up next
Jul 7
Navigating bone health: early life influences and advanced strategies for improvement and injury prevention (#214 rebroadcast)
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter In this episode from July 2022, Peter dives deep into the topic of bone health and explains why this is an important topic for everyone, from childr ... Show More
1h 31m
Jun 30
#355 – Skincare strategies, the science of facial aging, and cosmetic-intervention guidance | Tanuj Nakra, M.D. & Suzan Obagi, M.D.
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter Tanuj Nakra and Suzan Obagi, two leading experts in aesthetic medicine, join Peter to explore the science of facial aging and skin health as well as ... Show More
2h 57m
Jun 23
#354 – What the dying can teach us about living well: lessons on life and reflections on mortality | BJ Miller, M.D. and Bridget Sumser, L.C.S.W.
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter BJ Miller, a hospice and palliative care physician, and Bridget Sumser, a licensed social worker specializing in serious illness and end-of-life car ... Show More
2h 16m
Recommended Episodes
Apr 2
GLP-1, Wearables & Longevity: What You Need to Know – AMA with Gil & Ashley
Dr. Gil Blander and Ashley Reaver dive into the science behind GLP-1 agonists, a class of drugs originally developed for type 2 diabetes but now widely used for weight management and longevity. They explore how these medications work, their effects on appetite, metabolism, and in ... Show More
49m 25s
Jun 2024
2360: What You Need to Know About GLP-1 With Dr. Tyna Moore
How she got into practice and how she got into the GLP-1 space. (2:25) Peptide vs a drug. (10:45) The dose matters. (11:18) The GLP-1 deficiency factors. (15:50) Running into the resistance wall. (20:11) The downstream effects of GLP-1s on our metabolism. (22:15) The musculoskele ... Show More
1h 37m
Jun 2024
Q&A with Karen: Blood Clots & HRT, Mirena IUD, Loose Skin Post Weight Loss, Ovarian Failure, Amenorrhea, Weight Gain from HRT and MORE!
It’s time for another Q&A episode. I’m answering listener questions about bioidentical HRT, the risks associated with oral estrogens, and so much more. Additionally, we'll discuss the Mirena IUD's impact on hormone levels, address concerns about loose skin after weight loss, and ... Show More
1h 30m
Jul 2024
Microdosing Ozempic (GLP-1 weight loss): A Safer Approach with Dr Lauren Fitzgerald MD- Ep. 272
Send us a textDr. Jade Teta interviews Dr. Lauren Fitzgerald, an MD specializing in functional medicine, about the use of GLP-1 agonists (semaglutide, Tirzapatide, etc) for weight loss. Dr. Fitzgerald shares her experience using these compounds and how they have helped her and he ... Show More
51m 28s
Jul 2024
#829 Miracle Drug Dangers: "Shocking Side Effects Of Ozempic Nobody Talks About!" With Dr. Don Clum
Today, I am fortunate to have Dr. Don Clum with me for the fourth time. He is the founder and owner of Insulin Friendly Living, a virtual practice specializing in insulin resistance and advanced metabolic nutrition.  In this episode, Dr. Don Clum explains that one in eight adults ... Show More
1h 17m
Oct 2023
5 Tips for Successful Weight Loss: Expert Advice from Nurse Doza
In this podcast, Nurse Doza shares his passion for discussing weight loss and offers helpful tips for those on a weight loss journey. He talks about the importance of finding a supportive community, provides recommendations for supplements and blood work, and highlights the benef ... Show More
50m 31s
Jan 2025
Ep. 205 Weight Loss Medications & Impact on OSA with Dr. John Carter and Dr. Michael Weber
How are weight loss medications, like Ozempic, reshaping obstructive sleep apnea care? In this episode of the BackTable ENT podcast, host Dr. Gopi Shah discusses emerging weight loss medications and their impact on obstructive sleep apnea (OSA) with Dr. John Carter, a neurologist ... Show More
39m 23s
Oct 2024
#537: Appetite Regulation, Metabolic Compensation and More – Stephan Guyenet, PhD
This is an “ask me anything” (AMA) episode with Dr. Stephan Guyenet, an expert in obesity neuroscience and eating behavior. This episode was originally published on Sigma Nutrition Premium. If you’re interested in subscribing to Sigma Nutrition Premium, then check all the details ... Show More
1h 4m
Jun 2022
RHR Research Review: Medicinal Mushrooms, Gut Microbiota, Blood Sugar, Root-Causeism, and Nutrient Deficiency
In this episode of Revolution Health Radio, Chris Kresser covers some of the most interesting recently published research studies, shares some insights from his clinical practice, and discusses subjects he’s been thinking about lately. Topics covered in this episode include types ... Show More
1h 16m